The Impact of Severe Vitamin D Deficiency and Its Correction on Bone Mineral Density (BMD) in Postmenopausal Women
Vitamin D
2 other identifiers
interventional
32
1 country
1
Brief Summary
It is well known that postmenopausal women are at risk for osteoporosis. The study hypothesis is that vitamin D deficiency (≤17.5nmol/L) is frequently associated with osteomalacia and will cause low BMD estimation in DXA scan due to insufficient bone mineralization. We assume that among these postmenopausal women, Vitamin D treatment will improve bone mineralization and will cause a rapid increase in BMD. According to the results, bisphosphonates therapy may be an unnecessary treatment. The objective of this study is to evaluate the impact of severe vitamin D deficiency and its correction on Bone Mineral Density (BMD) in postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2012
CompletedFirst Posted
Study publicly available on registry
September 27, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedApril 5, 2019
April 1, 2019
6 years
September 24, 2012
April 3, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in BMD (Z score) following 10 months of vitamin D supplementation
Will be measured at 3 time points (repeated measures):at baseline visit, after 3-4 months and after 10 months of treatment
10-14 months
Secondary Outcomes (1)
To examine the effect of increasing vitamin D levels on other objective parameters such as PTH, calcium, phosphorus and other subjective parameters such as muscle weakness, according to comparison between baseline visit and end of study visit.
10-14 months
Study Arms (1)
Vitamin D treatment
EXPERIMENTALWe assume that among postmenopausal women, Vitamin D treatment will improve bone mineralization and will cause a rapid increase in BMD.
Interventions
Eligibility Criteria
You may qualify if:
- Signed Informed Consent.
- Female age 55-70
- At least 2 years past menopause
- (OH)D≤ 17.5nmol/L (≤7 ng/ml)
You may not qualify if:
- \. Vitamin D levels \> 30nmol/L in the past 2 years 2. Creatinine \> 1.2%mg 3. Calcium ≥ 10.2mg/dl 4. Current or previous vitamin D treatment over 2 weeks 5. Previous vitamin D treatment over 2 months in the past 2 years 6. BMI\>35 or BMI\<20 7. Menopause before age 45 8. Type 1 diabetes 9. Concomitant disease:
- Mal-absorptive diseases (Cystic Fibrosis, Crohn's, gastric bypass surgery, celiac disease)
- Rheumatoid arthritis
- Nephrotic syndrome
- Chronic renal failure
- Primary hyperparathyroidism
- Hyperthyroidism
- Malignancies excluding skin cancers (within the last 5 years)
- Kidney stones or history of renal colic 10. Medications:
- Steroids use (past or present)
- Anti rejection drugs in the last 5 years
- Anticonvulsant (carbamezapine, hydantoin, Phenobarbital etc) in the last 5 years
- Any anti osteoporotic medication: Prolia, Bisphosphonates, Teriperatide, Evista, Protelos, (past or present)
- Post menopausal HRT (in the last 10 years)
- Aromatase inhibitors: Femara, Arimadex (past or present)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Soroka University Medical Center
Beersheba, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Endocrinologist
Study Record Dates
First Submitted
September 24, 2012
First Posted
September 27, 2012
Study Start
October 1, 2012
Primary Completion
October 1, 2018
Study Completion
December 1, 2018
Last Updated
April 5, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share